US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Aya Gold & Silver Inc

18.01

+0.89005.20%

Post-market: 18.00-0.0100-0.06%18:21 EDT

Volume:573.68K

Turnover:10.28M

Market Cap:2.58B

PE:56.28

High:18.32

Open:17.94

Low:17.61

Close:17.12

52wk High:18.32

52wk Low:16.94

Shares:142.99M

Float Shares:96.63M

Volume Ratio:1.20

T/O Rate:0.59%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.3200

EPS(LYR):0.3200

ROE:13.81%

ROA:6.86%

PB:6.23

PE(LYR):56.28

Loading ...

Overview Company News Filings

Earning Preview: Amaya Q2 revenue is expected to increase by N/A, and institutional views are bullish

NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM

Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting

Artrya Limited (AYA) Receives a Buy from Bell Potter

Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center

Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Aya Gold & Silver (AYA) Gets a Buy from National Bank

Artrya Limited (AYA) Receives a Buy from Petra Capital

Raymond James Reaffirms Their Buy Rating on Aya Gold & Silver (AYA)

Aya Gold & Silver (AYA) Receives a Buy from Stifel Nicolaus

Artrya (ASX:AYA) Secures Cone Health In Five-Year SaaS Deal Is Its U.S. Beachhead Emerging?

Simply Wall St.

Fennec Pharmaceuticals Announces Investigator-Sponsored Trial to Be Conducted by City of Hope in Metastatic Testicular Germ Cell Tumors

Fennec Pharmaceuticals Announces Positive Topline Results From Investigator-Initiated Clinical Study of PEDMARK® in Japan to Reduce Cisplatin-Induced Hearing Loss

Aya Gold & Silver (AYA) Gets a Buy from CIBC

Assessing Artrya (ASX:AYA) Valuation Ahead of Q1 2026 Earnings Call

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AYA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AYA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AYA\",,,,,undefined,":{"symbol":"AYA","market":"US","secType":"STK","nameCN":"Aya Gold & Silver Inc","latestPrice":18.01,"timestamp":1778097600000,"preClose":17.12,"halted":0,"volume":573675,"hourTrading":{"tag":"盘后","latestPrice":18,"preClose":18.01,"latestTime":"18:21 EDT","volume":169091,"amount":3041470.41145,"timestamp":1778106101236,"change":-0.01,"changeRate":-0.000555,"amplitude":0.001666},"delay":0,"changeRate":0.05198598130841125,"floatShares":96630000,"shares":142986547,"eps":0.32,"marketStatus":"Not Yet Opened","change":0.89,"latestTime":"05-06 16:00:00 EDT","open":17.94,"high":18.32,"low":17.61,"amount":10280667.324975,"amplitude":0.041472,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.32,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1778140800000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1433736000000,"exchange":"NASDAQ","adjPreClose":17.12,"preHourTrading":{"tag":"盘前","latestPrice":17.92,"preClose":17.12,"latestTime":"09:00 EDT","volume":1699,"amount":31158.059542000003,"timestamp":1778072405851,"change":0.8,"changeRate":0.046729,"amplitude":0.126752},"postHourTrading":{"tag":"盘后","latestPrice":18,"preClose":18.01,"latestTime":"18:21 EDT","volume":169091,"amount":3041470.41145,"timestamp":1778106101236,"change":-0.01,"changeRate":-0.000555,"amplitude":0.001666},"volumeRatio":1.199432},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AYA\",,,,,undefined,":{"symbol":"AYA","floatShares":96630000,"roa":"6.86%","roe":"13.81%","lyrEps":0.319999,"volumeRatio":1.199432,"shares":142986547,"dividePrice":0,"high":18.32,"amplitude":0.041472,"preClose":17.12,"low":17.61,"week52Low":16.94,"pbRate":"6.23","psRate":"12.74","week52High":18.32,"institutionHeld":0,"latestPrice":18.01,"eps":0.32,"divideRate":0,"volume":573675,"delay":0,"ttmEps":0.32,"open":17.94,"prevYearClose":17.85,"prevWeekClose":17.85,"prevMonthClose":17.85,"prevQuarterClose":17.85,"earningDate":1778688000000,"earningTime":"盘前"},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AYA\",params:#limit:5,,,undefined,":[{"date":"2026-05-14","symbol":"AYA","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1778745600000,"name":null,"time":"Pre-Market","dateTimestamp":1778731200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AYA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AYA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":10,"updateTime":1760587200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AYA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AYA","date":"2026-05-05","current":56.28125,"percent":1,"low":55.951037,"twenty":55.951037,"median":55.951037,"eighty":55.951037,"high":55.951037,"avg":55.951037,"sd":0,"marketCap":2548961397.77},"quantilePoints":[{"date":"2026-05-05","current":55.951037,"twenty":55.951037,"median":55.951037,"eighty":55.951037,"marketCap":2548961397.77}],"updateTime":1778109074374},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AYA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1173784154","title":"Earning Preview: Amaya Q2 revenue is expected to increase by N/A, and institutional views are bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1173784154","media":"Earnings Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/1173784154?lang=en_us&edition=fundamental","pubTime":"2026-05-07 10:44","pubTimestamp":1778121844,"startTime":"0","endTime":"0","summary":"Abstract Amaya will announce its quarterly results on May 14, 2026 Pre-Market, and consensus currently centers on higher earnings per share year over year while investors watch revenue resilience,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Earning Preview: Amaya Q2 revenue is expected to increase by N/A, and institutional views are bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632936457","title":"NASDAQ TRADE HALT  REASON NOT AVAILABLE AT 04:00 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2632936457","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632936457?lang=en_us&edition=fundamental","pubTime":"2026-05-04 16:00","pubTimestamp":1777881602,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  REASON NOT AVAILABLE AT 04:00 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nAQN2LXHDM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629068631","title":"Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2629068631","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629068631?lang=en_us&edition=fundamental","pubTime":"2026-04-22 04:30","pubTimestamp":1776803400,"startTime":"0","endTime":"0","summary":"– Data from Four Studies Spotlight Rising Clinical Interest & Urgency to Address Cisplatin-Induced Hearing Loss and Its Lasting Impact on Patients – RESEARCH TRIANGLE PARK, N.C., April  21, 2026 (GLOB","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/21/3278477/0/en/Fennec-Pharmaceuticals-Announces-Acceptance-of-Abstracts-at-the-2026-ASCO-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4159","BK4213","BK4588","BK4585","AYA","GCT","GFR","BK4122","BK4139","FENC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629577744","title":"Artrya Limited (AYA) Receives a Buy from Bell Potter","url":"https://stock-news.laohu8.com/highlight/detail?id=2629577744","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629577744?lang=en_us&edition=fundamental","pubTime":"2026-04-21 08:07","pubTimestamp":1776730054,"startTime":"0","endTime":"0","summary":"In a report released today, Martyn Jacobs from Bell Potter maintained a Buy rating on Artrya Limited, with a price target of A$6.10. Jacobs covers ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/artrya-limited-aya-receives-a-buy-from-bell-potter-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/artrya-limited-aya-receives-a-buy-from-bell-potter-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625093241","title":"Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center","url":"https://stock-news.laohu8.com/highlight/detail?id=2625093241","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625093241?lang=en_us&edition=fundamental","pubTime":"2026-04-07 19:03","pubTimestamp":1775559780,"startTime":"0","endTime":"0","summary":"~ University of Arizona Cancer Center Initiating Study to Explore Use of PEDMARK in AYA & Adult Patients with Solid Tumors Receiving Cisplatin ~  ~ This New Study and Other Independent, Institution-Le","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/07/3268978/0/en/Fennec-Pharmaceuticals-Announces-Investigator-Sponsored-Study-to-Be-Conducted-by-University-of-Arizona-Cancer-Center.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4203","FENC","BK4213","GFR","CIO","AYA","BK4223","HR","BK4139","BK4225","BK4194"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621066095","title":"Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2621066095","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621066095?lang=en_us&edition=fundamental","pubTime":"2026-03-24 19:00","pubTimestamp":1774350000,"startTime":"0","endTime":"0","summary":"~ Delivered Record Annual Revenue with Full-Year Net PEDMARKProduct Sales of $44.6 Million, Representing 50% Year-Over-Year Growth, and Q4 2025 Net Product Sales of $13.8 Million, Representing 75% Gro","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/24/3261052/0/en/Fennec-Pharmaceuticals-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4223","FENC","GFR","BK4194","BK4213","BK4139","AYA","CIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614633640","title":"Aya Gold & Silver (AYA) Gets a Buy from National Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2614633640","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614633640?lang=en_us&edition=fundamental","pubTime":"2026-02-26 07:56","pubTimestamp":1772063790,"startTime":"0","endTime":"0","summary":"In a report released today, from National Bank maintained a Buy rating on Aya Gold & Silver, with a price target of C$25.00. In a report released o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/aya-gold-silver-aya-gets-a-buy-from-national-bank-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/aya-gold-silver-aya-gets-a-buy-from-national-bank-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NBHC","SImain","AYA","159934","GCmain","MGCmain","SGCmain","SGUmain","GDX","518880","IAU","NUGT","DUST","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608581603","title":"Artrya Limited (AYA) Receives a Buy from Petra Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2608581603","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608581603?lang=en_us&edition=fundamental","pubTime":"2026-02-03 07:36","pubTimestamp":1770075400,"startTime":"0","endTime":"0","summary":"Petra Capital analyst Tanushree Jain maintained a Buy rating on Artrya Limited today and set a price target of A$6.27. According to TipRanks, Jain ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/artrya-limited-aya-receives-a-buy-from-petra-capital-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/artrya-limited-aya-receives-a-buy-from-petra-capital-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603647336","title":"Raymond James Reaffirms Their Buy Rating on Aya Gold & Silver (AYA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2603647336","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603647336?lang=en_us&edition=fundamental","pubTime":"2026-01-15 05:49","pubTimestamp":1768427356,"startTime":"0","endTime":"0","summary":"In a report released today, Craig Stanley from Raymond James maintained a Buy rating on Aya Gold & Silver, with a price target of C$27.00. Accordin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/raymond-james-reaffirms-their-buy-rating-on-aya-gold-silver-aya-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/raymond-james-reaffirms-their-buy-rating-on-aya-gold-silver-aya-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AYA","RJF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603160646","title":"Aya Gold & Silver (AYA) Receives a Buy from Stifel Nicolaus","url":"https://stock-news.laohu8.com/highlight/detail?id=2603160646","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603160646?lang=en_us&edition=fundamental","pubTime":"2026-01-14 21:19","pubTimestamp":1768396767,"startTime":"0","endTime":"0","summary":"In a report released today, Ingrid Rico from Stifel Nicolaus reiterated a Buy rating on Aya Gold & Silver, with a price target of C$31.50. Rico cov...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/aya-gold-silver-aya-receives-a-buy-from-stifel-nicolaus-blurbs-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/aya-gold-silver-aya-receives-a-buy-from-stifel-nicolaus-blurbs-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SGUmain","518880","GDX","GCmain","MGCmain","BK4127","SImain","SGCmain","IAU","AYA","NUGT","SF","159934","DUST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594263302","title":"Artrya (ASX:AYA) Secures Cone Health In Five-Year SaaS Deal Is Its U.S. Beachhead Emerging?","url":"https://stock-news.laohu8.com/highlight/detail?id=2594263302","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594263302?lang=en_us&edition=fundamental","pubTime":"2025-12-26 04:25","pubTimestamp":1766694313,"startTime":"0","endTime":"0","summary":"Artrya Limited recently announced a five-year SaaS agreement with U.S. healthcare provider Cone Health to roll out its Salix Coronary Anatomy and Plaque AI imaging modules across the health system’s network, securing its third commercial customer in the United States.\nThis latest deal completes the conversion of all three of Artrya’s U.S. foundation partners, signalling growing clinical adoption and a deeper foothold in the competitive American cardiac imaging market.\nWe’ll now examine how...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-aya/artrya-shares/news/artrya-asxaya-secures-cone-health-in-five-year-saas-deal-is","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-aya/artrya-shares/news/artrya-asxaya-secures-cone-health-in-five-year-saas-deal-is","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AYA","BK7094","AYA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590343077","title":"Fennec Pharmaceuticals Announces Investigator-Sponsored Trial to Be Conducted by City of Hope in Metastatic Testicular Germ Cell Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2590343077","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590343077?lang=en_us&edition=fundamental","pubTime":"2025-12-09 20:00","pubTimestamp":1765281600,"startTime":"0","endTime":"0","summary":"– City of Hope to Evaluate PEDMARK for Reducing Ototoxicity in Adult Men with Stage II-III Metastatic Testicular Germ Cell Tumors –  – Initiation of Study Reflects Growing Clinical Interest in Address","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/09/3202214/0/en/Fennec-Pharmaceuticals-Announces-Investigator-Sponsored-Trial-to-Be-Conducted-by-City-of-Hope-in-Metastatic-Testicular-Germ-Cell-Tumors.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4211","BK4194","CHCO","BK4213","CIO","FENC","GFR","BK4223","HOPE","AYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588030920","title":"Fennec Pharmaceuticals Announces Positive Topline Results From Investigator-Initiated Clinical Study of PEDMARK® in Japan to Reduce Cisplatin-Induced Hearing Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2588030920","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588030920?lang=en_us&edition=fundamental","pubTime":"2025-12-02 20:01","pubTimestamp":1764676860,"startTime":"0","endTime":"0","summary":"– Study, Which Enrolled 27 Patients, Met Primary Endpoint with a Significant Reduction in Hearing Loss in 3-18 Year Old Patients who Received PEDMARK when Compared with Historically Reported Rates of ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/02/3197763/0/en/Fennec-Pharmaceuticals-Announces-Positive-Topline-Results-From-Investigator-Initiated-Clinical-Study-of-PEDMARK-in-Japan-to-Reduce-Cisplatin-Induced-Hearing-Loss.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4213","GFR","AYA","BK4139","FENC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2583309692","title":"Aya Gold & Silver (AYA) Gets a Buy from CIBC","url":"https://stock-news.laohu8.com/highlight/detail?id=2583309692","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583309692?lang=en_us&edition=fundamental","pubTime":"2025-11-13 01:27","pubTimestamp":1762968470,"startTime":"0","endTime":"0","summary":"CIBC analyst Cosmos Chiu maintained a Buy rating on Aya Gold & Silver today and set a price target of C$25.00. According to TipRanks, Chiu is a 5-s...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/aya-gold-silver-aya-gets-a-buy-from-cibc-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/aya-gold-silver-aya-gets-a-buy-from-cibc-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SImain","GCmain","518880","SGCmain","SGUmain","IAU","AYA","DUST","1OZmain","NUGT","GDX","MGCmain","159934"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2582903468","title":"Assessing Artrya (ASX:AYA) Valuation Ahead of Q1 2026 Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2582903468","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582903468?lang=en_us&edition=fundamental","pubTime":"2025-11-09 18:23","pubTimestamp":1762683799,"startTime":"0","endTime":"0","summary":"Artrya (ASX:AYA) is on investors’ radar this week, as anticipation grows ahead of its Q1 2026 earnings call scheduled for October 29, 2025. Market watchers are waiting to see how recent trends translate into results.\nSee our latest analysis for Artrya.\nMomentum has been building for Artrya, with a 27.6% share price return over the past month and a remarkable 445.2% year-to-date. Over the last twelve months, total shareholder return stands at an impressive 576.0%, highlighting the surge in...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-aya/artrya-shares/news/assessing-artrya-asxaya-valuation-ahead-of-q1-2026-earnings","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-aya/artrya-shares/news/assessing-artrya-asxaya-valuation-ahead-of-q1-2026-earnings","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AYA","AYA.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}]}}